Drugs / PDE-5 inhibitors group
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02422277 Comparator | Mar 2015 → Mar 2017 | urinary bladder cancer | Mansoura University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PDE-5 inhibitors group | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02422277 ↗ |
| Route | Oral | “oral intake once daily for 6 monthes” NCT02422277 ↗ |